Craig I Coleman

15.6k total citations
406 papers, 11.2k citations indexed

About

Craig I Coleman is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics. According to data from OpenAlex, Craig I Coleman has authored 406 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 227 papers in Cardiology and Cardiovascular Medicine, 114 papers in Internal Medicine and 59 papers in Economics and Econometrics. Recurrent topics in Craig I Coleman's work include Atrial Fibrillation Management and Outcomes (163 papers), Venous Thromboembolism Diagnosis and Management (114 papers) and Health Systems, Economic Evaluations, Quality of Life (57 papers). Craig I Coleman is often cited by papers focused on Atrial Fibrillation Management and Outcomes (163 papers), Venous Thromboembolism Diagnosis and Management (114 papers) and Health Systems, Economic Evaluations, Quality of Life (57 papers). Craig I Coleman collaborates with scholars based in United States, Germany and Canada. Craig I Coleman's co-authors include C Michael White, William L. Baker, Jeffrey Kluger, Diana M Sobieraj, Olivia J Phung, Thomas J. Bunz, Brendan Limone, Ripple Talati, Stephen Sander and Nitesh Sood and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Oncology.

In The Last Decade

Craig I Coleman

389 papers receiving 10.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Craig I Coleman United States	56	4.8k	2.0k	2.0k	1.3k	1.1k	406	11.2k
Fernando Laņas Chile	35	6.5k 1.4×	3.0k 1.5×	736 0.4×	2.5k 2.0×	1.5k 1.3×	198	13.4k
Emil Loldrup Fosbøl Denmark	56	5.2k 1.1×	2.0k 1.0×	915 0.5×	869 0.7×	1.8k 1.6×	420	11.1k
Luis A. Garcı́a Rodrı́guez Spain	65	3.8k 0.8×	4.1k 2.1×	577 0.3×	1.5k 1.1×	1.6k 1.4×	282	15.3k
José Carlos Nicolau Brazil	46	4.8k 1.0×	2.7k 1.4×	829 0.4×	1.4k 1.1×	717 0.6×	339	9.3k
Tabassome Simon France	54	5.1k 1.1×	2.9k 1.5×	687 0.3×	1.0k 0.8×	2.0k 1.8×	292	12.4k
Joseph B. Muhlestein United States	57	4.1k 0.9×	2.5k 1.3×	447 0.2×	1.4k 1.1×	2.2k 1.9×	241	11.5k
Stefan Agewall Norway	46	6.1k 1.3×	2.8k 1.4×	376 0.2×	1.1k 0.9×	804 0.7×	228	10.9k
Ron J.G. Peters Netherlands	41	7.5k 1.6×	4.3k 2.2×	1.8k 0.9×	818 0.6×	797 0.7×	222	11.2k
Kristian B. Filion Canada	50	4.2k 0.9×	2.0k 1.0×	515 0.3×	2.9k 2.3×	1.7k 1.5×	283	11.8k
Jean Ferrières France	64	6.5k 1.4×	4.0k 2.0×	511 0.3×	2.9k 2.3×	2.0k 1.7×	524	15.5k

Countries citing papers authored by Craig I Coleman

Since Specialization

Citations

This map shows the geographic impact of Craig I Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig I Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig I Coleman more than expected).

Fields of papers citing papers by Craig I Coleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig I Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig I Coleman. The network helps show where Craig I Coleman may publish in the future.

Co-authorship network of co-authors of Craig I Coleman

This figure shows the co-authorship network connecting the top 25 collaborators of Craig I Coleman. A scholar is included among the top collaborators of Craig I Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig I Coleman. Craig I Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fan, Huanhuan, Fariba Donovan, Belinda Lovelace, & Craig I Coleman. (2025). Coccidioidomycosis-Attributable Death in the United States: An Analysis of Cases Reported on Death Certificates, 2018–2023. Journal of Fungi. 11(11). 766–766.

Coleman, Craig I, et al.. (2025). The Burden of Hospital Illness Associated with Disseminated Versus Isolated Pulmonary Coccidioidomycosis in the United States. Journal of Fungi. 11(2). 161–161.

Williams, James M., Belinda Lovelace, Mary J. Christoph, et al.. (2023). Clinical and health care resource use burden of hospitalizations for oral factor Xa inhibitor‐associated major bleeding: A real‐world analysis of Medicare beneficiaries. SHILAP Revista de lepidopterología. 4(3). e12956–e12956. 5 indexed citations

Becattini, Cecilia, Marc Carrier, Alexander T. Cohen, et al.. (2023). Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding. SHILAP Revista de lepidopterología. 7(3). e206–e216. 6 indexed citations

Beyer‐Westendorf, Jan, Veronica Ashton, Dejan Milentijevic, et al.. (2020). Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data. Current Medical Research and Opinion. 36(7). 1081–1088. 30 indexed citations

Bowrin, Kevin, J Brière, Laurent Fauchier, et al.. (2020). Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France. PLoS ONE. 15(1). e0225301–e0225301. 10 indexed citations

Coleman, Craig I, Reinhold Kreutz, Nitesh Sood, et al.. (2019). Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis. The American Journal of Medicine. 132(9). 1078–1083. 91 indexed citations

Peacock, W. Frank, Craig I Coleman, Philip S. Wells, et al.. (2019). Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care. Journal of health economics and outcomes research. 6(3). 160–173. 1 indexed citations

Coleman, Craig I, et al.. (2017). Effectiveness and Safety of Rivaroxaban Vs. Warfarin in Patients with Nonvalvular Atrial Fibrillation and Moderate-to-Severe Chronic Kidney Disease. Blood. 130. 2393–2393. 5 indexed citations

10.

Coleman, Craig I, Erin R. Weeda, Elaine Nguyen, Thomas J. Bunz, & Nitesh Sood. (2017). Abstract 16513: Effectiveness and Safety of Rivaroxaban versus Warfarin in Patients 80+ Years of Age With Nonvalvular Atrial Fibrillation. Circulation. 1 indexed citations

11.

Wang, Li, Onur Başer, Philip S. Wells, et al.. (2016). Abstract 13112: Benefit of Early Discharge Among Patients With Low-risk Pulmonary Embolism: Focus on Net Clinical Impact. Circulation. 134(suppl_1). 1 indexed citations

12.

Coleman, Craig I & Brendan Limone. (2013). Cost-effectiveness of universal versus assay-driven antiplatelet therapy in acute coronary syndrome patients. Value in Health. 16(3). A284–A284.

13.

Phung, Olivia J, et al.. (2011). Oral anti‐diabetic drugs for the prevention of Type 2 diabetes. Diabetic Medicine. 28(8). 948–964. 28 indexed citations

14.

Coleman, Craig I, et al.. (2009). Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease. 8 indexed citations

15.

Talati, Ripple, et al.. (2009). The Effects of Barley-Derived Soluble Fiber on Serum Lipids. The Annals of Family Medicine. 7(2). 157–163. 90 indexed citations

16.

Baker, William L., et al.. (2008). Dopamine agonists in the treatment of early Parkinson's disease: A meta-analysis. Parkinsonism & Related Disorders. 15(4). 287–294. 53 indexed citations

17.

Jennings, Douglas L., et al.. (2007). Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta‐analysis. Diabetic Medicine. 24(5). 486–493. 97 indexed citations

18.

Coleman, Craig I, et al.. (2007). Preoperative statins and infectious complications following cardiac surgery. Current Medical Research and Opinion. 23(8). 1783–1790. 47 indexed citations

19.

Coleman, Craig I, et al.. (2007). Journal publications by pharmacy practice faculty evaluated by institution and region of the United States (2001-2003). Pharmacy Practice. 5(4). 151–6. 5 indexed citations

20.

Henyan, Nickole N., Effie L. Gillespie, C Michael White, Jeffrey Kluger, & Craig I Coleman. (2005). Impact of Intravenous Magnesium on Post-Cardiothoracic Surgery Atrial Fibrillation and Length of Hospital Stay: A Meta-Analysis. The Annals of Thoracic Surgery. 80(6). 2402–2406. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact